Objective:

The interview with OptraSCAN Chief Product Officer Devika Gholap discusses barriers to digital pathology adoption, changing work habits, AI-enabled scanning, quality control, and affordability.

Approach:

• Source: Interview with Devika Gholap, Chief Product Officer at OptraSCAN.
• Topics: Adoption barriers, changing work habits, AI-enabled scanning, quality control, affordability, and future development.

Key Findings:

• Gholap identifies cost as the biggest barrier, noting that scanners and related systems can cost many times more than a microscope.
• She says pathologists’ established microscope habits require adjustment to digital workflows, while residents and students are increasingly trained with digital pathology.
• She anticipates scanning and AI analysis could occur in parallel, with preliminary analysis and triage completed before cases reach pathologists.
• She describes slide and image quality control as foundational and says algorithms can assess image quality and flag issues related to tissue or sample preparation.
• Gholap says affordability needs greater focus across the industry and that reducing scanner costs could make adoption more accessible to laboratories.

Interpretation:

Gholap says wider adoption depends in part on lowering costs and adapting to digital workflows. She also describes potential parallel scanning and analysis, preliminary case triage, and automated quality checks.

Limitations:

• The source is an interview with an industry executive and presents her perspectives rather than study results.
• The supplied context ends mid-sentence as Gholap begins to describe what the industry must address to make digital pathology more accessible.

Sources: